239 Pill - white capsule/oblong, 18mm
Pill with imprint 239 is White, Capsule/Oblong and has been identified as Ziprasidone Hydrochloride 60 mg. It is supplied by Cadila Healthcare Limited.
Ziprasidone is used in the treatment of Autism; Bipolar Disorder; Schizoaffective Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Ziprasidone 60 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 239
Ziprasidone Hydrochloride
- Imprint
- 239
- Strength
- 60 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1181
- Inactive Ingredients
-
alcohol,
ammonia,
butyl alcohol,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
lactose monohydrate,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
corn starch,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "239"
More about ziprasidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (477)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Patient resources
- Ziprasidone drug information
- Ziprasidone (Intramuscular) (Advanced Reading)
- Ziprasidone (Oral) (Advanced Reading)
- Ziprasidone Capsules
- Ziprasidone Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
